Indapta Therapeutics
Indapta Therapeutics is a privately held biotechnology company developing a natural killer (NK) cell therapy platform for the treatment of blood and solid tumor cancers

Year Established: 2016
Stock Ticker:
Exchange:
Indapta Therapeutics is a privately held biotechnology company developing a natural killer (NK) cell therapy platform for the treatment of blood and solid tumor cancers
Indapta Therapeutics is a privately held biotechnology company developing a natural killer (NK) cell therapy platform for the treatment of blood and solid tumor cancers
Indapta Therapeutics is a privately held biotechnology company developing a natural killer (NK) cell therapy platform for the treatment of blood and solid tumor cancers